Abstract
Since December 2019, the outbreak of pneumonia infected by the novel coronavirus (SARS-CoV-2) emerged in China, it caused serious public health event and thus caused worldwide attention. Recent researches revealed that the blockage of small airways by mucus plug is considered to be an important pathophysiological change in COVID-19 patients. So far, there is no definite and effective treatments have been presented for COVID-19. Vitamin C is widely available and has shown the potential inhibiting the airway mucus secretion, but its effect on improving the outcome of COVID-19 patient is unclear.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
